I'm LongbridgeAI, I can summarize articles.The Week
Monster Beverage (MNST) rose 1.62% this week to close at $46.46, underperforming the S&P 500, which gained 2.51% over the same period. The week started soft: shares opened Monday at $45.57, dipped to a weekly low of $44.88, then hovered around $45 through Tuesday and Wednesday. Thursday brought a modest rebound, and Friday saw a push to a weekly high of $46.52 before settling near the top of the range. Volume was slightly below the stock’s 60-day median daily pace.
Key Events
This week’s news flow centred on earnings momentum and valuation. On Tuesday, Bernstein maintained Monster Beverage at Market Perform and raised its price target to $51 from $50 — the only direct broker update during the week. Over the weekend, two more headlines appeared: one noting McKesson Corp. outperforming competitors on a strong trading day, and another asking whether Monster Beverage is a bargain following strong earnings growth. There were no new product launches, earnings, or regulatory developments from the company itself this week; the main thread was the market weighing solid earnings against the current multiple.
Analyst Ratings
Of the 26 institutions covering the stock, 11 rate it buy, 3 rate it overweight, 10 rate it hold, 1 rates it underweight, and 1 has no opinion; none rate it sell. The consensus recommendation is buy, with a consensus target of $50.13, about 7.9% above the current price of $46.46. Target prices range from $37 to $57, a wide spread that points to real disagreement on how far earnings can go. Within the water and soft drinks industry, Monster Beverage ranks first among 16 peers, with above-average analyst coverage.
The Week Ahead
Next week is heavy on US macro data. Monday brings the New York Fed manufacturing index, with consensus at 18 versus a prior reading of 25.5. Tuesday packs in import prices, retail sales ex-autos, retail sales, industrial production, and the NAHB housing market index. On the company side, Monster Beverage’s FY2026 annual results are scheduled for 25 February 2027 after market close, so no direct earnings event lands next week. The macro calendar can still move the stock indirectly through rate expectations and consumer-staples sentiment.
In Short
Monster Beverage posted a modest gain that lagged the broader market this week. The widely held buy rating and a consensus target above spot sit alongside a very wide target range, which suggests the Street is split on the pace of earnings delivery. The next leg likely depends on how macro data affects consumer sentiment and whether fresh fundamentals emerge to justify the current valuation.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
